Combined tDCS and Pneumatic Compression for Recovery After a 10K Run
NCT07333404, Not applicable, Completed, Uludag University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Combined tDCS and Pneumatic Compression for Recovery After a 10K Run | ClinicalTrials.gov |
| NCT number | NCT07333404 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 16 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Uludag University | ClinicalTrials.gov |
| Conditions | Recovery Methods, Muscle Fatigue, Exercise Performance Recovery, Endurance Exercise | ClinicalTrials.gov |
| Interventions | Transcranial Direct Current Stimulation (tDCS), Normatec Pneumatic Compression | ClinicalTrials.gov |
| First posted | 2026-01-12 | ClinicalTrials.gov |
| Last updated | 2026-06-03 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Maximal Voluntary Isometric Contraction (MVIC) | Assessments will be performed immediately before the 10-kilometer run, immediately after completion of the 10-kilometer run, and immediately after the recovery intervention. | Maximal voluntary isometric contraction (MVIC) of the quadriceps muscles (vastus lateralis, rectus femoris, and vastus medialis) will be measured using surface electromyography (EMG) to assess neuromuscular function and fatigue. Participants will perform three contractions lasting 3 to 5 seconds each, with 60-second rest intervals, while seated with the knee and hip joints positioned at 90 degrees. | ClinicalTrials.gov |
| Primary | Heart Rate Variability (HRV) | Immediately before 10K run, immediately after 10K run, immediately after recovery intervention | Heart rate variability will be measured using the Polar Vantage V3 GPS watch with H10 heart rate sensor to assess autonomic nervous system responses to exercise and recovery interventions. HRV parameters will be analyzed to evaluate physiological stress and recovery. Measurements will be recorded at rest for 5 minutes in a seated position. | ClinicalTrials.gov |
| Primary | Cognitive Performance: Stroop Test | Immediately before 10K run, immediately after 10K run, immediately after recovery intervention | Cognitive performance will be assessed using the computerized Stroop Test. Participants will respond to color-word stimuli where the color of the word may be congruent or incongruent with the written word. Reaction time and accuracy will be recorded to evaluate cognitive function and executive control in response to exercise and recovery interventions. | ClinicalTrials.gov |
| Secondary | Total Quality Recovery (TQR) | Immediately before the 10-kilometer run (T1), immediately after the 10-kilometer run (T2), and immediately after the recovery intervention (T3). | Participants will self-report perceived recovery using the Total Quality of Recovery scale, assessing overall recovery status after exercise and recovery interventions. Scores range from 1 to 10, with higher scores indicating better recovery quality. | ClinicalTrials.gov |
| Secondary | Well-Being Questionnaire (WBQ) | Immediately before the 10-kilometer run (T1), immediately after the 10-kilometer run (T2), and immediately after the recovery intervention (T3). | Participants will complete the Well-Being Questionnaire to evaluate subjective measures of mood, fatigue, and general well-being in response to exercise and recovery interventions. Scores range from 1 to 5, with higher scores indicating better well-being. | ClinicalTrials.gov |
| Secondary | Vertical Jump | Immediately before 10K run, immediately after 10K run, immediately after recovery intervention | Participants will perform three maximum effort vertical jumps at one-minute intervals. Jump height will be measured using the MyJump app to assess neuromuscular performance after exercise and recovery interventions. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 2
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)